The researchers want the U.S. Food and Drug Administration to require drug manufacturers to state how new medications compare with similar, existing treatments. In many instance, these statements would indicate that there is no evidence that a new drug is more effective than older ones.Click here to access the individual.com article. Click here to access the researchers' article published in the NEJM (free full text).
The Stanford researchers recommend that the FDA require new treatments to carry a label that would read, for instance: "Although this drug has been shown to lower blood pressure more effectively than placebo, it has not been shown to be more effective than other members of the same drug class."
Thursday, August 13, 2009
Stanford researchers, comparative research, and labeling
From the individual.com article: